[1]
|
Coppola L, Cianflone A, Grimaldi AM, et al. Biobanking in health care: evolution and future directions[J]. J Transl Med, 2019, 17:172. doi: 10.1186/s12967-019-1922-3 |
[2]
|
Quinlan PR, Groves M, Jordan LB, et al. The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network[J]. Biopreserv Biobank, 2015, 13: 363-370. doi: 10.1089/bio.2014.0099 |
[3]
|
满秋红, 于农, 闫飞, 等.我国生物样本库建设现状与未来发展的思考[J].中国医药生物技术, 2018, 13: 289-293. doi: 10.3969/j.issn.1673-713X.2018.04.001 |
[4]
|
徐艳, 樊萍, 胡迅.生物样本库建设的关键问题及解决策略[J].华西医学, 2018, 33: 651-654. |
[5]
|
郜恒骏, 杜莉利, 张小燕, 等.生物样本库发展的现状、机遇与挑战[J].协和医学杂志, 2018, 9: 172-176. doi: 10.3969/j.issn.1674-9081.2018.02.013 |
[6]
|
翟培军, 李军燕, 胡冬梅, 等.生物样本库国际认可和标准化发展与前景[J].中华临床实验室管理电子杂志, 2017, 5: 6-8. doi: 10.3877/cma.j.issn.2095-5820.2017.01.003 |
[7]
|
Haga SB, Beskow LM. Ethical, legal, and social implica-tions of biobanks for genetics research[J]. Adv Genet, 2008, 60: 505-544. doi: 10.1016/S0065-2660(07)00418-X |
[8]
|
Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality[J]. Pharmacogenomics, 2005, 6: 639-646. doi: 10.2217/14622416.6.6.639 |
[9]
|
Fearn P, Michels C, Meagher K, et al. 2012 International Society for Biological and Environmental Repositories Informatics Working Group: survey results and conclusions[J]. Biopreserv Biobank, 2013, 11: 64-66. doi: 10.1089/bio.2012.1115 |
[10]
|
Vaught J. Biobanking Comes of Age: The Transition to Biospecimen Science[J]. Annu Rev Pharmacol Toxicol, 2016, 56: 211-228. doi: 10.1146/annurev-pharmtox-010715-103246 |
[11]
|
Quinlan PR, Gardner S, Groves M, et al. A Data-Centric Strategy for Modern Biobanking[J]. Adv Exp Med Biol, 2015, 864: 165-169. |
[12]
|
De Souza YG, Greenspan JS.Biobanking past, present and future: responsibilities and benefits[J]. AIDS, 2013, 27: 303-312. doi: 10.1097/QAD.0b013e32835c1244 |
[13]
|
Zhu S, Shen M, Qiu X, et al. Ethical management guidelines for the shanghai disease-based biobank network[J]. Biopreserv Biobank, 2015, 13: 8-12. doi: 10.1089/bio.2014.0087 |
[14]
|
Baker M. Biorepositories: Building better biobanks[J]. Nature, 2012, 486: 141-146. doi: 10.1038/486141a |
[15]
|
Zamboni WC, Torchilin V, Patri AK, et al.Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance[J]. Clin Cancer Res, 2012, 18: 3229-3241. doi: 10.1158/1078-0432.CCR-11-2938 |
[16]
|
郭丹, 杨文航, 徐英春.临床生物样本库信息系统建设与发展[J].协和医学杂志, 2018, 9: 81-86. doi: 10.3969/j.issn.1674-9081.2018.01.015 |
[17]
|
Rush A, Byrne JA. Quality and reporting practices in an Australian cancer biobank cohort[J]. Clin Biochem, 2016, 49: 492-497. doi: 10.1016/j.clinbiochem.2015.12.007 |
[18]
|
Betsou F, Sobel ME. The ISBER Biorepository proficiency testing program: two successful years already, and new features to come[J]. Biopreserv Biobank, 2013, 11: 255-256. doi: 10.1089/bio.2013.1143 |
[19]
|
Vaught J, Campbell LD, Betsou F, et al. The ISBER Best Practices: Insight from the Editors of the Third Edition[J]. Biopreserv Biobank, 2012, 10: 76-78. doi: 10.1089/bio.2012.1024 |